UBS AM’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.11M Buy
49,805
+14,892
+43% +$331K ﹤0.01% 2366
2025
Q1
$649K Buy
34,913
+5,434
+18% +$101K ﹤0.01% 2441
2024
Q4
$390K Sell
29,479
-3,405
-10% -$45.1K ﹤0.01% 2587
2024
Q3
$1.1M Buy
32,884
+3,223
+11% +$108K ﹤0.01% 2355
2024
Q2
$743K Buy
29,661
+12,740
+75% +$319K ﹤0.01% 2506
2024
Q1
$381K Hold
16,921
﹤0.01% 2351
2023
Q4
$362K Hold
16,921
﹤0.01% 2388
2023
Q3
$304K Hold
16,921
﹤0.01% 2433
2023
Q2
$368K Hold
16,921
﹤0.01% 2413
2023
Q1
$368K Buy
+16,921
New +$368K ﹤0.01% 2413
2022
Q4
Sell
-23,007
Closed -$587K 2560
2022
Q3
$587K Buy
23,007
+8,361
+57% +$213K ﹤0.01% 2274
2022
Q2
$297K Sell
14,646
-8,361
-36% -$170K ﹤0.01% 2482
2022
Q1
$569K Hold
23,007
﹤0.01% 2421
2021
Q4
$799K Sell
23,007
-1,307
-5% -$45.4K ﹤0.01% 2328
2021
Q3
$659K Hold
24,314
﹤0.01% 2369
2021
Q2
$630K Buy
24,314
+9,668
+66% +$251K ﹤0.01% 2443
2021
Q1
$316K Sell
14,646
-2,227
-13% -$48K ﹤0.01% 2479
2020
Q4
$363K Hold
16,873
﹤0.01% 2382
2020
Q3
$249K Hold
16,873
﹤0.01% 2347
2020
Q2
$377K Buy
16,873
+2,524
+18% +$56.4K ﹤0.01% 2223
2020
Q1
$203K Buy
+14,349
New +$203K ﹤0.01% 2275
2019
Q4
Sell
-99,518
Closed -$3.48M 2542
2019
Q3
$3.48M Sell
99,518
-2,516
-2% -$88K ﹤0.01% 1355
2019
Q2
$5.76M Buy
102,034
+4,164
+4% +$235K ﹤0.01% 1154
2019
Q1
$7.15M Buy
97,870
+3,935
+4% +$287K 0.01% 1031
2018
Q4
$5.99M Sell
93,935
-9,813
-9% -$626K 0.01% 1022
2018
Q3
$10.4M Buy
103,748
+10,098
+11% +$1.01M 0.01% 928
2018
Q2
$6.65M Buy
93,650
+22,193
+31% +$1.58M 0.01% 1057
2018
Q1
$7.44M Buy
71,457
+83
+0.1% +$8.64K 0.01% 1009
2017
Q4
$7.19M Buy
+71,374
New +$7.19M 0.01% 996